Yi Luo

Title: Yi Luo: Innovator in Nanobody Research

Introduction

Yi Luo is a prominent inventor based in Jiangsu, China, known for his significant contributions to the field of nanobody research. He holds three patents that focus on innovative solutions for detecting and analyzing viral infections, particularly influenza A and SARS-CoV-2.

Latest Patents

His latest patents include a nanobody targeting influenza A virus nucleoprotein and its application, as well as a nucleic acid encoding the nanobody. The first patent describes a nanobody that specifically binds to the influenza A virus nucleoprotein, which can be utilized for early warning systems regarding influenza outbreaks and for environmental or human detection of the virus. The second patent outlines a preparation method for a single-chain antibody fragment targeting the SARS-CoV-2 nucleocapsid protein. This fragment exhibits high affinity and specificity, making it suitable for various immunoassay platforms related to SARS-CoV-2 detection.

Career Highlights

Yi Luo is affiliated with Nanjing University, where he continues to advance his research in the field of nanobodies. His work has broad application prospects in the medical field, particularly in the detection and analysis of viral pathogens.

Collaborations

He collaborates with notable colleagues such as Shixiang Yang and Wenjin Hu, contributing to the advancement of research in nanobody technology.

Conclusion

Yi Luo's innovative work in nanobody research positions him as a key figure in the fight against viral infections, showcasing the potential of his inventions in public health applications.